Clinical Trials

NCT07072585 | NOT_YET_RECRUITING | PHASE2/PHASE3
1708 participants

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2026-08-28
Completion:
2035-09-01
Conditions
  • Stage II T Lymphoblastic Leukemia/Lymphoma
  • Stage III T Lymphoblastic Leukemia/Lymphoma
  • Stage IV T Lymphoblastic Leukemia/Lymphoma
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
Interventions
  • DRUG
  • OTHER
  • RADIATION
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT07024758 | ACTIVE_NOT_RECRUITING | NA
174 participants

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2025-07-01
Completion:
2028-06-30
Conditions
  • Obsessive Compulsive Disorder (OCD)
  • Anxiety Disorder of Childhood or Adolescence
  • Social Anxiety Disorder of Childhood
  • Generalized Anxiety Disorder (GAD)
  • Separation Anxiety Disorder
  • Panic Disorder
  • Panic Attacks
  • Panic Disorder (With or Without Agoraphobia)
  • Phobia, Specific
Interventions
  • BEHAVIORAL
No Results Yet
NCT07024563 | RECRUITING | PHASE3
36 participants

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2025-06-14
Completion:
2028-11-29
Conditions
  • IgAN
  • IgAVN
  • Immunoglobulin A Nephropathy
  • Immunoglobulin A Vasculitis Associated Nephritis
  • Henoch-schonlein Purpura Nephritis
  • IgA Vasculitis
Interventions
  • DRUG
No Results Yet
NCT06947460 | RECRUITING | PHASE1/PHASE2
45 participants

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2025-04-18
Completion:
2026-07-31
Conditions
  • Refractory Lupus Nephritis
  • Systemic Sclerosis
  • Primary Sjogren's Syndrome Combined With Pulmonary Hypertension
  • Other Autoimmune Diseases (AID)
Interventions
  • DRUG
No Results Yet
NCT06947304 | ACTIVE_NOT_RECRUITING | PHASE1
9 participants

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2025-08-22
Completion:
2026-08-31
Conditions
  • Nonalcoholic Steatohepatitis (NASH)
  • Metabolic Dysfunction-Associated Steatohepatitis (MASH)
  • Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page